Utilization of Parallel Resources and Sociodemographic Factors in Treating Children with Complex Chronic Diseases: A

Bibiana Pérez-Ardanaz1, María José Peláez-Cantero2, María González-Cano-Caballero3

  • 1Faculty of Health Sciences, Universidad de Málaga, 29071 Málaga, Spain.

Insights

Many parents of children with complex chronic conditions use additional healthcare resources. Parental education and occupation influence the use of these parallel health services, potentially impacting health equity.

Area of Science:

  • Pediatric Healthcare
  • Health Services Research
  • Social Determinants of Health

Background:

  • Children with complex chronic conditions require extensive health and social care.
  • Parents often seek supplementary resources like alternative therapies and private consultations.
  • The utilization of these parallel resources may exacerbate health inequalities.

Purpose of the Study:

  • To characterize the use of alternative healthcare resources for children with complex chronic conditions.
  • To evaluate how sociodemographic factors influence the utilization of these resources.

Main Methods:

  • Cross-sectional study conducted at a tertiary hospital in Granada, Spain (2016).
  • Analysis of healthcare resource utilization and socioeconomic variables for 265 children.
  • Research adhered to STROBE guidelines for observational studies.

Main Results:

  • 39.6% of children had private specialist consultations; 12.1% had private health insurance.
  • One-third of parents joined mutual support associations; 26% used alternative therapies.
  • Children with parents of higher educational and occupational status utilized more parallel healthcare resources.

Conclusions:

  • A significant number of children access multiple health resources beyond the public system, influenced by sociodemographic factors.
  • Further research is necessary to ascertain if these alternative services improve health outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
425
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
280
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
33